Researcher
Kai Dallmeier
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Nov 2008 → 30 Sep 2022
Projects
1 - 10 of 21
- Yellow fever serology assaysFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Effect of insulin and feed/fast cycle on vaccine efficacy and safetyFrom1 Oct 2023 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- MucorVax – Development of a first-in-class fungal vaccine candidateFrom1 Oct 2023 → TodayFunding: IOF - technology concept exploration
- Role of autoantibodies against type I IFN in the pathogenicity of SARS-CoV-2 and YFVFrom18 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GynCoviRisk – Assessing the risk of SARS-CoV-2 for pregnancy and as possible cause of birth defects.From1 Apr 2023 → TodayFunding: Horizon Europe - Marie Skłodowska-Curie-actions
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Optimization of large plasmid DNA production in bioreactorsFrom28 Oct 2022 → TodayFunding: BOF - doctoral mandates, Baekeland
- Next Steps in HBV Vaccine Research: Novel Small Animal Models for HBV Infection and Innovative Microneedle Patch-Based Vaccine Delivery MethodsFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Viruses as tool and target: A Synthetic Biology approach towards exceptionally potent prophylactic and therapeutic vaccinesFrom1 Oct 2022 → TodayFunding: BOF - ZAP BOF mandates
- Assessing the risk of SARS-CoV-2 infection for pregnancy and as a possible cause of birth defectsFrom20 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 79
- YF17D-based vaccines - standing on the shoulders of a giant.(2024)
Authors: Ji Ma, Lotte Coelmont, Kai Dallmeier
Pages: e2250133 - SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts(2024)
Authors: Wannes Verbist, Jolien Breukers, Iene Rutten, Hans Gerstmans, Kai Dallmeier, Jeroen Lammertyn
- Multiplexed multicolor antiviral assay amenable for high-throughput research(2024)
Authors: Li-Hsin Li, Yun-An Huang, Madina Rasulova, Hendrik Jan Thibaut, Sebastiaan ter Horst, Joana Duarte Da Rocha Pereira, Suzanne Kaptein, Pieter Leyssen, Johan Neyts, Kai Dallmeier
- Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters(2023)
Authors: Rana Abdelnabi, Winnie Kerstens, Hendrik Jan Thibaut, Lotte Coelmont, Birgit Weynand, Johan Neyts, Kai Dallmeier
- Ex vivo gut cultures of Aedes aegypti are efficiently infected by mosquito-borne alpha- and flaviviruses(2023)
Authors: Arno Cuvry, Li-Hsin Li, Kai Dallmeier, Joana Duarte Da Rocha Pereira, Leen Delang
- YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge(2023)
Authors: Viktor Lemmens, Lara Kelchtermans, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier
- Validation of a Reporter Cell Line for Flavivirus Inhibition Assays(2023)
Authors: Hendrik Jan Thibaut, Kai Dallmeier, Johan Neyts
- Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates(2023)
Authors: Suzanne Kaptein, Kai Dallmeier, Johan Neyts
Pages: 678 - + - Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters(2022)
Authors: Sapna Sharma, Winnie Kerstens, Madina Rasulova, Rana Abdelnabi, Viktor Lemmens, Piet Maes, Guy Baele, Birgit Weynand, Philippe Lemey, Johan Neyts, et al.
- Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models(2022)
Authors: Ji Ma, Sander Jansen, Birgit Weynand, Patrick Matthys, Tania Roskams, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
Patents
1 - 10 of 10
- Lassavirus vaccines (Inventor)
- Large vectors and methods for high-yield production (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Coronavirus vaccines (Inventor)
- Large vectors and methods for high-yield production (Inventor)
- Chimeric flavivirus lyssavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)